BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Beckers A, Petrossians P, Hanson J, Daly AF. The causes and consequences of pituitary gigantism. Nat Rev Endocrinol 2018;14:705-20. [DOI: 10.1038/s41574-018-0114-1] [Cited by in Crossref: 38] [Cited by in F6Publishing: 19] [Article Influence: 9.5] [Reference Citation Analysis]
Number Citing Articles
1 Kubicka AM, Charlier P, Balzeau A. The Internal Cranial Anatomy of a Female With Endocrine Disorders From a Mediaeval Population. Front Endocrinol 2022;13:862047. [DOI: 10.3389/fendo.2022.862047] [Reference Citation Analysis]
2 Melmed S, Kaiser UB, Lopes MB, Bertherat J, Syro LV, Raverot G, Reincke M, Johannsson G, Beckers A, Fleseriu M, Giustina A, Wass JAH, Ho KKY. Clinical Biology of the Pituitary Adenoma. Endocr Rev 2022:bnac010. [PMID: 35395078 DOI: 10.1210/endrev/bnac010] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
3 Franke M, Daly AF, Palmeira L, Tirosh A, Stigliano A, Trifan E, Faucz FR, Abboud D, Petrossians P, Tena JJ, Vitali E, Lania AG, Gómez-Skarmeta JL, Beckers A, Stratakis CA, Trivellin G. Duplications disrupt chromatin architecture and rewire GPR101-enhancer communication in X-linked acrogigantism. Am J Hum Genet 2022;109:553-70. [PMID: 35202564 DOI: 10.1016/j.ajhg.2022.02.002] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
4 Sirufo MM, Magnanimi LM, Ginaldi L, De Martinis M. The true story of the "strong and gentle" Acciano's Giant. Growth Horm IGF Res 2022;63:101457. [PMID: 35334425 DOI: 10.1016/j.ghir.2022.101457] [Reference Citation Analysis]
5 Kobalka PJ, Huntoon K, Becker AP. Neuropathology of Pituitary Adenomas and Sellar Lesions. Neurosurgery 2021;88:900-18. [PMID: 33476394 DOI: 10.1093/neuros/nyaa548] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
6 Lee Y, Kang T, Cho HR, Lee GJ, Park OK, Kim S, Lee B, Kim HM, Cha GD, Shin Y, Lee W, Kim M, Kim H, Song YM, Choi SH, Hyeon T, Kim DH. Localized Delivery of Theranostic Nanoparticles and High-Energy Photons using Microneedles-on-Bioelectronics. Adv Mater 2021;33:e2100425. [PMID: 33955598 DOI: 10.1002/adma.202100425] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 12.0] [Reference Citation Analysis]
7 Watanabe LP, Riddle NC. GWAS reveal a role for the central nervous system in regulating weight and weight change in response to exercise. Sci Rep 2021;11:5144. [PMID: 33664357 DOI: 10.1038/s41598-021-84534-w] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
8 Li B, Wang X, Yang C, Wen S, Li J, Li N, Long Y, Mu Y, Liu J, Liu Q, Li X, Desiderio DM, Zhan X. Human growth hormone proteoform pattern changes in pituitary adenomas: Potential biomarkers for 3P medical approaches. EPMA J 2021;12:67-89. [PMID: 33786091 DOI: 10.1007/s13167-021-00232-7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
9 Coopmans EC, Korevaar TIM, van Meyel SWF, Daly AF, Chanson P, Brue T, Delemer B, Hána V, Colao A, Carvalho D, Jaffrain-Rea ML, Stalla GK, Fajardo-Montañana C, Beckers A, van der Lely AJ, Petrossians P, Neggers SJCMM. Multivariable Prediction Model for Biochemical Response to First-Generation Somatostatin Receptor Ligands in Acromegaly. J Clin Endocrinol Metab 2020;105:dgaa387. [PMID: 32589751 DOI: 10.1210/clinem/dgaa387] [Cited by in Crossref: 6] [Cited by in F6Publishing: 11] [Article Influence: 6.0] [Reference Citation Analysis]
10 Kline GA. Coexisting failures do not diminish the stature of a giant. CMAJ 2021;193:E104. [PMID: 33462150 DOI: 10.1503/cmaj.77486] [Reference Citation Analysis]
11 Hinrichs A, Riedel EO, Klymiuk N, Blutke A, Kemter E, Längin M, Dahlhoff M, Keßler B, Kurome M, Zakhartchenko V, Jemiller EM, Ayares D, Bidlingmaier M, Flenkenthaler F, Hrabĕ de Angelis M, Arnold GJ, Reichart B, Fröhlich T, Wolf E. Growth hormone receptor knockout to reduce the size of donor pigs for preclinical xenotransplantation studies. Xenotransplantation 2021;28:e12664. [PMID: 33241624 DOI: 10.1111/xen.12664] [Cited by in Crossref: 3] [Cited by in F6Publishing: 12] [Article Influence: 1.5] [Reference Citation Analysis]
12 Abboud D, Daly AF, Dupuis N, Bahri MA, Inoue A, Chevigné A, Ectors F, Plenevaux A, Pirotte B, Beckers A, Hanson J. GPR101 drives growth hormone hypersecretion and gigantism in mice via constitutive activation of Gs and Gq/11. Nat Commun 2020;11:4752. [PMID: 32958754 DOI: 10.1038/s41467-020-18500-x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
13 Gummadavelli A, Dinauer C, McGuone D, Vining EM, Erson-Omay EZ, Omay SB. Large-scale second-hit AIP deletion causing a pediatric growth hormone-secreting pituitary adenoma: Case report and review of literature. J Clin Neurosci 2020;78:420-2. [PMID: 32336638 DOI: 10.1016/j.jocn.2020.04.103] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
14 Vasilev V, Daly AF, Zacharieva S, Beckers A. Clinical and Molecular Update on Genetic Causes of Pituitary Adenomas. Horm Metab Res 2020;52:553-61. [PMID: 32299111 DOI: 10.1055/a-1143-5930] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
15 Han S, Ma E, Jiang W, Lu Y, Sun X, Feng S. Overrepresentation of highly functional T regulatory cells in patients with nonfunctioning pituitary adenoma. Hum Immunol 2020;81:314-9. [PMID: 32279926 DOI: 10.1016/j.humimm.2020.03.007] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
16 Villa C, Vasiljevic A, Jaffrain-Rea ML, Ansorge O, Asioli S, Barresi V, Chinezu L, Gardiman MP, Lania A, Lapshina AM, Poliani L, Reiniger L, Righi A, Saeger W, Soukup J, Theodoropoulou M, Uccella S, Trouillas J, Roncaroli F. A standardised diagnostic approach to pituitary neuroendocrine tumours (PitNETs): a European Pituitary Pathology Group (EPPG) proposal. Virchows Arch 2019;475:687-92. [PMID: 31578606 DOI: 10.1007/s00428-019-02655-0] [Cited by in Crossref: 27] [Cited by in F6Publishing: 32] [Article Influence: 9.0] [Reference Citation Analysis]
17 Argente J, Tatton-Brown K, Lehwalder D, Pfäffle R. Genetics of Growth Disorders-Which Patients Require Genetic Testing? Front Endocrinol (Lausanne) 2019;10:602. [PMID: 31555216 DOI: 10.3389/fendo.2019.00602] [Cited by in Crossref: 10] [Cited by in F6Publishing: 20] [Article Influence: 3.3] [Reference Citation Analysis]
18 Daly AF, Rostomyan L, Betea D, Bonneville JF, Villa C, Pellegata NS, Waser B, Reubi JC, Waeber Stephan C, Christ E, Beckers A. AIP-mutated acromegaly resistant to first-generation somatostatin analogs: long-term control with pasireotide LAR in two patients. Endocr Connect 2019;8:367-77. [PMID: 30851160 DOI: 10.1530/EC-19-0004] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 6.3] [Reference Citation Analysis]
19 Daly AF, Cano DA, Venegas-Moreno E, Petrossians P, Dios E, Castermans E, Flores-Martínez A, Bours V, Beckers A, Soto-Moreno A. AIP and MEN1 mutations and AIP immunohistochemistry in pituitary adenomas in a tertiary referral center. Endocr Connect 2019;8:338-48. [PMID: 30822274 DOI: 10.1530/EC-19-0027] [Cited by in Crossref: 15] [Cited by in F6Publishing: 9] [Article Influence: 5.0] [Reference Citation Analysis]